OMOP Concept 4178507
Drug therapy observable
StandardObservationSNOMED363819003Observable Entity
Maps from
20
Descendants
1,009
Valid from
31 Jan 2002
Valid to
31 Dec 2099
OMOP concepts
Concept Lookup Tool
Search 11M+ concepts across SNOMED, RxNorm, ICD-10 & LOINC.
Source codes that map to this concept
20 source codes normalize to Drug therapy observable via the OMOP "Maps to" relationship.
Synonyms
Alternative names recorded for Drug therapy observable across source vocabularies.
- característica observable del tratamiento farmacológico
- característica observable del tratamiento farmacológico (entidad observable)
- Drug therapy observable (observable entity)
Where it sits in the hierarchy
Ordered by distance - 1 is a direct parent or child.
Narrower concepts
(1,009)Included automatically when you query with descendants.
- 1Ability to manage medication
- 1Anti-diabetic drug therapy observation
- 1Antidiabetic drug therapy observation
- 1Blood product unit attribute
- 1Current medication as reported by general practitioner
- 1Current medication as reported by patient
- 1Date chemotherapy completed
- 1Drug observable
- 1Drug tolerance
- 1Duration of anticoagulant therapy
- 1Duration of antiplatelet therapy
- 1Medication compliance
- 1Medication response
- 1Medication review due date
- 1Number of times bronchodilator used per week
- 1Number of times reliever inhaler used per week
- 1Planned stop date for clopidogrel therapy
- 1Platelet aggregation inhibitor therapy contraindication
- 1Rate of administration of intravenous fluid
- 1World Health Organization Antiretroviral therapy guidelines
- 211-Beta-hydroxyaetiocholanolone/creatinine mass concentration ratio in urine
- 211-Beta-hydroxyandrosterone/creatinine mass concentration ratio in urine
- 217-Alpha-hydroxypregnanolone/creatinine mass concentration ratio in urine
- 217-Alpha hydroxypregnanolone/creatinine molar concentration ratio in urine
- 25-Alpha tetrahydrocortisol/5-beta tetrahydrocortisol molar concentration ratio in urine
- 26-Methylmercaptopurine/6-thioguanine molar concentration ratio in red blood cells
- 2Ability to administer subcutaneous injection
- 2Ability to manage medication using memory technique
- 2Ability to obtain medication
- 2Ability to self-administer medication
- 2Ability to store medications
- 2Accumulation ratio minimum concentration
- 2Adrenaline/creatinine molar concentration ratio in urine
- 2Aetiocholanolone/creatinine mass concentration ratio in urine
- 2Aldosterone/renin molar concentration ratio in plasma
- 2alpha-1 Antitrypsin mass content in faeces
- 2alpha-1-antitrypsin phenotype in blood
- 2alpha-1-antitrypsin phenotype in serum
- 2alpha-2-Antiplasmin percent activity in plasma
- 2Ambulant renin enzyme activity in plasma
- 2Amfetamine in oral fluid qualitative result
- 2Amfetamine in urine qualitative result
- 2Androstenedione/testosterone molar concentration ratio in plasma
- 2Androsterone/creatinine mass concentration ratio in urine
- 2Anesthetic agent concentration
- 2Antithrombin III percent activity in plasma
- 2APC (activated protein C) with factor V deficient plasma percent in plasma
- 2APCR (activated protein C resistance) presence in plasma
- 2APTT (activated partial thrombin time) by PNP (platelet neutralisation procedure) correction
- 2Bence Jones protein/creatinine mass concentration ratio in urine
Get this concept via the API
Resolve Drug therapy observable - and every code that maps to it - over HTTPS, against the current vocabulary release. No downloads, no local database.
curl "https://api.omophub.com/v1/concepts/4178507?include_relationships=true" \
-H "Authorization: Bearer $OMOPHUB_API_KEY"Get your free API key3,000 calls/month free · no credit card